Treatment in carbon monoxide poisoning patients with headache: a prospective, multicenter, double-blind, controlled clinical trial - 02/11/16
Abstract |
Background |
There is a lack of specificity of the analgesic agents used to treat headache and underlying acute carbon monoxide poisoning.
Objective |
To compare effectiveness of “oxygen alone” vs “metoclopramide plus oxygen” vs “metamizole plus oxygen” therapy in treating carbon monoxide–induced headache.
Design |
A prospective, multicenter, double-blind, controlled trial.
Setting |
Three emergency departments in Turkey.
Population |
Adult carbon monoxide poisoning patients with headache.
Methods |
A total of 117 carbon monoxide-intoxicated patients with headache were randomized into 3 groups and assessed at baseline, 30 minutes, 90 minutes, and 4 hours.
Main Outcome Measure |
The primary outcome was patient-reported improvement rates for headache. Secondary end points included nausea, need for rescue medication during treatment, and reduction in carboxyhemoglobin levels.
Results |
During observation, there was no statistical difference between drug type and visual analog scale score change at 30 minutes, 90 minutes, or 4 hours, for either headache or nausea. No rescue medication was needed during the study period. The reduction in carboxyhemoglobin levels did not differ among the 3 groups.
Conclusion |
The use of “oxygen alone” is as efficacious as “oxygen plus metoclopramide” or “oxygen plus metamizole sodium” in the treatment of carbon monoxide–induced headache.
Le texte complet de cet article est disponible en PDF.Plan
☆ | Conflict of interest statement: None. |
☆☆ | Financial support: None declared. |
Vol 34 - N° 11
P. 2140-2145 - novembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?